
Sprycel 20mg Tablet
Marketer
BMS India Pvt Ltd
Salt Composition
Dasatinib (20mg)
Overview Sprycel 20mg Tablet
Dasatinib 20mg tablets are indicated for treating chronic myeloid leukemia (CML). This medication is prescribed for patients whose leukemia hasn't responded to, or who can't tolerate, other leukemia treatments. Dasatinib 20mg tablets may be taken with or without food, but consistent daily timing maximizes effectiveness. Dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's instructions; incorrect usage or overdose can lead to serious adverse effects. Therapeutic benefits might not be immediately apparent, taking weeks or months; discontinue only under medical supervision. Common side effects include nausea, vomiting, stomach pain, and skin rash. Increased heart rate, and high or low blood pressure, though less frequent, warrant immediate medical attention; regular blood pressure monitoring may be necessary. Avoid antacids within two hours of taking this medication. Dasatinib can lower blood cell counts, increasing infection risk, necessitating regular blood tests. Inform your healthcare provider of all other medications you're taking, as interactions are possible. This medicine is contraindicated during pregnancy and breastfeeding. Refrain from driving if dizziness or visual disturbances occur.
Uses of Sprycel 20mg Tablet
Chronic myeloid leukemia, a type of blood malignancy
Major Benefits of Sprycel 20mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Sprycel 20mg Tablet can be administered with or without food, although consistent timing is recommended.
Common Side effects of Sprycel 20mg Tablet:
- Abdominal pain
- Anemia (low number of red blood cells)
- Breathing problems
- Fatigue
- Fever
- Headache
- Infection
- Low blood platelets
- Musculoskeletal (bone, muscle or joint) pain
- Nausea
- Rash
- Vomiting
How to use Sprycel 20mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Sprycel 20mg Tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, however, consistent timing is recommended.
How Sprycel 20mg Tablet works:
Bosutinib 20mg tablets are a cancer treatment that inhibits the activity of a faulty protein responsible for cancer cell proliferation, thereby curbing or retarding tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Sprycel 20mg Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Bosutinib 20mg tablets pose a confirmed risk to a developing fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Bosutinib 20mg tablets are contraindicated during lactation. Evidence indicates potential infant toxicity associated with this medication.
DrivingUNSAFE
Driving ability may be impaired by side effects of Sprycel 20mg Tablets, such as dizziness or blurred vision. Exercise caution while driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Dasatinib 20mg tablets are likely safe for individuals with impaired kidney function. Current evidence indicates dose modification may not be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Dasatinib 20mg tablets are considered safe for use in individuals with hepatic impairment. No alteration of the dasatinib 20mg tablet dosage is advised.
What if you forget to take Sprycel 20mg Tablet :
Omit any missed Sprycel 20mg Tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Sprycel 20mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Pyrimidine and Thiazole Derivatives |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Actions | Kinase inhibitors targeting tyrosine |
